Technology-Enabled Team Care for High Blood Pressure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help individuals with a history of uncontrolled high blood pressure (hypertension) manage their condition. It compares a team-based care approach, which includes home blood pressure monitoring and pharmacist support for medication and lifestyle advice, to regular care with basic instructions. Participants should have a history of uncontrolled high blood pressure, indicated by high readings despite treatment. The goal is to determine if the technology-enabled team care approach can better manage blood pressure and improve overall health outcomes. As an unphased trial, this study provides participants the chance to contribute to innovative care strategies that could enhance hypertension management for many.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop your current medications. However, a pharmacist will work with you to adjust your medications as needed to manage your blood pressure.
What prior data suggests that this model of care is safe for managing high blood pressure?
Research shows that using technology in healthcare, as in this trial, is generally safe. Studies have found that technology for monitoring blood pressure can help patients manage their high blood pressure more effectively. For example, one study found that patients using telemonitoring were 2.69 times more likely to control their blood pressure. This suggests the technology helps maintain blood pressure without causing harm.
Other studies have highlighted benefits such as early detection of blood pressure issues, improved medication use, and better overall management of high blood pressure. Importantly, these studies did not report major safety problems, indicating that the technology is well-tolerated.
While specific safety data for this trial is unavailable, the absence of reported adverse events in previous studies is promising. The technology has proven safe in similar situations. Overall, evidence suggests this approach to managing high blood pressure is safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about Technology-Enabled Team Care for high blood pressure because it offers a comprehensive and personalized approach that goes beyond traditional treatments. Unlike standard care where patients primarily rely on their usual doctor, this method involves a team-based approach led by a pharmacist, integrating telephonic management. It utilizes cellular-enabled home blood pressure monitoring, which allows for more frequent and convenient tracking of blood pressure levels. This approach also emphasizes personalized interventions, including medication management, diet, and exercise adjustments, and even referrals for social issues, aiming for a holistic improvement in patient health.
What evidence suggests that this trial's treatments could be effective for high blood pressure?
This trial will compare Technology-enabled Team Care with Enhanced Usual Care for managing high blood pressure. Research has shown that technology in team care effectively lowers blood pressure in people with uncontrolled high blood pressure. In one study, patients using this method saw their blood pressure drop from an average of 156/85 mm Hg to 131/75 mm Hg over 12 months. Another study found that telemonitoring and remote medical advice improved blood pressure control and was more cost-effective than regular care. Additionally, a nationwide study reported a 70% increase in patients reaching their blood pressure goals. Team-based care, where healthcare professionals collaborate, has proven to improve blood pressure control.13678
Who Is on the Research Team?
Doyle Cummings, Pharm.D.
Principal Investigator
East Carolina University Brody School of Medicine
Are You a Good Fit for This Trial?
This trial is for adults over 18 with a history of uncontrolled high blood pressure, particularly Hispanic and non-Hispanic black (majority) and white individuals. Participants must have had an average systolic BP of at least 140 mmHg in the past year and speak English without needing an interpreter. Those with severe kidney disease, dementia, substance abuse issues, or pregnant women are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive ongoing team-based, pharmacist-led telephonic management of uncontrolled high blood pressure involving cellular-enabled home BP monitoring, medications, diet and exercise, and referral for social problems
Follow-up
Participants are monitored for changes in systolic blood pressure and other outcomes at 6 and 12 months
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Usual Care
- Technology-enabled Team Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
East Carolina University
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator
University of North Carolina, Chapel Hill
Collaborator